Structural requirements for TLR7-selective signaling by 9-(4-piperidinylalkyl)-8-oxoadenine derivatives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structural requirements for TLR7-selective signaling by 9-(4-piperidinylalkyl)-8-oxoadenine derivatives

Published:2015-03 Issue:6 Volume:25 Page:1318-1323
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Bazin Hélène G.,Li Yufeng,Khalaf Juhienah K.,Mwakwari Sandra,Livesay Mark T.,Evans Jay T.,Johnson David A.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. Toll-like receptor signalling

2. The history of Toll-like receptors — redefining innate immunity

3. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily

4. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances on Small-Molecule Antagonists Targeting TLR7;Molecules;2023-01-07

2. Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination;Scientific Reports;2022-10-18

3. Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants;Advanced Drug Delivery Reviews;2021-08

4. Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors;Journal of Medicinal Chemistry;2021-06-10

5. Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles;RSC Medicinal Chemistry;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3